Gaia Medical Pty Ltd is excited to announce its partnership with DEBx Medical B.V. and are delighted to offer DEBRICHEM® to Australian wound care Clinicians. DEBRICHEM® is an innovative, single use treatment, that desiccates the biofilm, as well as residing and planktonic micro-organisms within 60-seconds of application.
By instantly capturing water molecules from any type of exposed biological tissue, DEBRICHEM® has an immediate dehydrating effect, with no damage to the vital tissue below the wound bed.
DEBRICHEM® is safe on intact skin and allows the wound to rapidly continue onto the granulation phase of healing, often without the reliance on antibiotic treatments, which means it is a breakthrough product for antimicrobial stewardship associated with wound care.
“DEBRICHEM® has allowed us to quickly and cost-effectively address the removal of biofilm and infected tissue, facilitating optimal wound bed preparation for early application of other advanced technologies [….] It has also allowed us to rationalize the use of antibiotics and avoid the risk of antibiotic resistance and other problems related to antibiotic treatments”
Dr. Joan Enric Torra I Bou, Clinical Consultant and Researcher. Doctorate Programme in Health Sciences, Universitat de Lleida, Lleida, Spain.
With DEBRICHEM®, patients may also benefit from a reduction in chronic wound pain which is caused by the infection and inflammation of the wound. Healthcare professionals will benefit from simplified workflows as hard-to-heal wounds are reset on a healing trajectory often with just one treatment. Hospitals and Clinics can benefit from reduced operational costs and efficiency, positively impacting patient throughput, satisfaction, and quality of life.
We are excited to share how DEBRICHEM® can help your patients and practice, please contact our Clinical Sales team on (AU) +61 472 752 575 or email customer.service@gaiamedical.com.au
The Team at Gaia Medical